Furthermore, empirical evidence from a murine model of high-fat diet-induced NAFLD revealed that empagliflozin administration resulted in an elevated Bcl2/Bax ratio, suppression of Caspase-8 cleavage, and reduced hepatocyte apoptosis [124]. This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatotic liver disease.